[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

VPAResearch: Market Research Reports

VPA Research is one of the global pharmaceutical companies specialized in analysis of clinical trials. We provide leading insights into global Pharma products, pipeline research, companies and drugs markets.

Publications found: 58,333
Sort by:

Hepatic Encephalopathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hepatic Encephalopathy PIPELINE HIGHLIGHTS Hepatic Encephalopathy is one of the widely researched conditions during 2020 with 12 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 79 pages

Hidradenitis Suppurativa pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hidradenitis Suppurativa PIPELINE HIGHLIGHTS Hidradenitis Suppurativa is one of the widely researched conditions during 2020 with 19 companies actively focusing on realizing pipeline’s potential....

July 2020 126 pages

Hives (Chronic Urticaria) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hives (Chronic Urticaria) PIPELINE HIGHLIGHTS Hives (Chronic Urticaria) is one of the widely researched conditions during 2020 with 25 companies actively focusing on realizing pipeline’s potentia...

July 2020 120 pages

Hypereosinophilic Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hypereosinophilic Syndrome PIPELINE HIGHLIGHTS Hypereosinophilic Syndrome is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potenti...

July 2020 48 pages

Hypertrophic Cardiomyopathy pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hypertrophic Cardiomyopathy PIPELINE HIGHLIGHTS Hypertrophic Cardiomyopathy is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s poten...

July 2020 52 pages

Hypoparathyroidism pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hypoparathyroidism PIPELINE HIGHLIGHTS Hypoparathyroidism is one of the widely researched conditions during 2020 with 11 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 61 pages

Hypotension pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hypotension PIPELINE HIGHLIGHTS Hypotension is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Hypotension...

July 2020 48 pages

Hypothyroidism pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Hypothyroidism PIPELINE HIGHLIGHTS Hypothyroidism is one of the widely researched conditions during 2020 with 7 companies actively focusing on realizing pipeline’s potential. Development of Hypot...

July 2020 48 pages

Idiopathic Thrombocytopenic Purpura (ITP) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Idiopathic Thrombocytopenic Purpura (ITP) PIPELINE HIGHLIGHTS Idiopathic Thrombocytopenic Purpura (ITP) is one of the widely researched conditions during 2020 with 23 companies actively focusing...

July 2020 104 pages

Intermittent Claudication pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Intermittent Claudication PIPELINE HIGHLIGHTS Intermittent Claudication is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potential...

July 2020 42 pages

Interstitial Cystitis (Painful Bladder Syndrome) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Interstitial Cystitis (Painful Bladder Syndrome) PIPELINE HIGHLIGHTS Interstitial Cystitis (Painful Bladder Syndrome) is one of the widely researched conditions during 2020 with 14 companies acti...

July 2020 74 pages

Iron Deficiency Anemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Iron Deficiency Anemia PIPELINE HIGHLIGHTS Iron Deficiency Anemia is one of the widely researched conditions during 2020 with 13 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 69 pages

Irritable Bowel Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Irritable Bowel Syndrome PIPELINE HIGHLIGHTS Irritable Bowel Syndrome is one of the widely researched conditions during 2020 with 34 companies actively focusing on realizing pipeline’s potential....

July 2020 145 pages

Ischemia Reperfusion Injury pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Ischemia Reperfusion Injury PIPELINE HIGHLIGHTS Ischemia Reperfusion Injury is one of the widely researched conditions during 2020 with 38 companies actively focusing on realizing pipeline’s pote...

July 2020 170 pages

Ischemic Heart Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Ischemic Heart Disease PIPELINE HIGHLIGHTS Ischemic Heart Disease is one of the widely researched conditions during 2020 with 39 companies actively focusing on realizing pipeline’s potential. Dev...

July 2020 176 pages

Keloids pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Keloids PIPELINE HIGHLIGHTS Keloids is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Keloids medicines i...

July 2020 53 pages

Kidney Fibrosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Kidney Fibrosis PIPELINE HIGHLIGHTS Kidney Fibrosis is one of the widely researched conditions during 2020 with 32 companies actively focusing on realizing pipeline’s potential. Development of Ki...

July 2020 132 pages

Left Ventricular Dysfunction pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Left Ventricular Dysfunction PIPELINE HIGHLIGHTS Left Ventricular Dysfunction is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s pot...

July 2020 42 pages

Liver Cirrhosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Liver Cirrhosis PIPELINE HIGHLIGHTS Liver Cirrhosis is one of the widely researched conditions during 2020 with 26 companies actively focusing on realizing pipeline’s potential. Development of Li...

July 2020 126 pages

Liver Failure pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Liver Failure PIPELINE HIGHLIGHTS Liver Failure is one of the widely researched conditions during 2020 with 23 companies actively focusing on realizing pipeline’s potential. Development of Liver...

July 2020 112 pages

Meniere Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Meniere Disease PIPELINE HIGHLIGHTS Meniere Disease is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Men...

July 2020 45 pages

Myocardial Fibrosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Myocardial Fibrosis PIPELINE HIGHLIGHTS Myocardial Fibrosis is one of the widely researched conditions during 2020 with 14 companies actively focusing on realizing pipeline’s potential. Developme...

July 2020 71 pages

Myocardial Ischemia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Myocardial Ischemia PIPELINE HIGHLIGHTS Myocardial Ischemia is one of the widely researched conditions during 2020 with 11 companies actively focusing on realizing pipeline’s potential. Developme...

July 2020 61 pages

Myocarditis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Myocarditis PIPELINE HIGHLIGHTS Myocarditis is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potential. Development of Myocarditis...

July 2020 40 pages

Nasal Polyps pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Nasal Polyps PIPELINE HIGHLIGHTS Nasal Polyps is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential. Development of Nasal Pol...

July 2020 54 pages

Nasopharyngitis (Common Cold) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Nasopharyngitis (Common Cold) PIPELINE HIGHLIGHTS Nasopharyngitis (Common Cold) is one of the widely researched conditions during 2020 with 7 companies actively focusing on realizing pipeline’s p...

July 2020 50 pages

Nephrotic Syndrome pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Nephrotic Syndrome PIPELINE HIGHLIGHTS Nephrotic Syndrome is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 52 pages

Neutropenia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Neutropenia PIPELINE HIGHLIGHTS Neutropenia is one of the widely researched conditions during 2020 with 24 companies actively focusing on realizing pipeline’s potential. Development of Neutropeni...

July 2020 118 pages

Nocturia pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Nocturia PIPELINE HIGHLIGHTS Nocturia is one of the widely researched conditions during 2020 with 5 companies actively focusing on realizing pipeline’s potential. Development of Nocturia medicine...

July 2020 45 pages

Oral Mucositis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Oral Mucositis PIPELINE HIGHLIGHTS Oral Mucositis is one of the widely researched conditions during 2020 with 16 companies actively focusing on realizing pipeline’s potential. Development of Oral...

July 2020 96 pages

Otitis Media pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Otitis Media PIPELINE HIGHLIGHTS Otitis Media is one of the widely researched conditions during 2020 with 12 companies actively focusing on realizing pipeline’s potential. Development of Otitis M...

July 2020 68 pages

Overactive Bladder pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Overactive Bladder PIPELINE HIGHLIGHTS Overactive Bladder is one of the widely researched conditions during 2020 with 25 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 112 pages

Pancreatitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Pancreatitis PIPELINE HIGHLIGHTS Pancreatitis is one of the widely researched conditions during 2020 with 23 companies actively focusing on realizing pipeline’s potential. Development of Pancreat...

July 2020 106 pages

Paroxysmal Nocturnal Hemoglobinuria pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Paroxysmal Nocturnal Hemoglobinuria PIPELINE HIGHLIGHTS Paroxysmal Nocturnal Hemoglobinuria is one of the widely researched conditions during 2020 with 18 companies actively focusing on realizing...

July 2020 106 pages

Peptic Ulcers pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Peptic Ulcers PIPELINE HIGHLIGHTS Peptic Ulcers is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development of Peptic...

July 2020 56 pages

Periodontitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Periodontitis PIPELINE HIGHLIGHTS Periodontitis is one of the widely researched conditions during 2020 with 13 companies actively focusing on realizing pipeline’s potential. Development of Period...

July 2020 65 pages

Peripheral Arterial Disease (PAD) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Peripheral Arterial Disease (PAD) PIPELINE HIGHLIGHTS Peripheral Arterial Disease (PAD) is one of the widely researched conditions during 2020 with 34 companies actively focusing on realizing pip...

July 2020 164 pages

Peripheral Vascular Disease (PVD) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Peripheral Vascular Disease (PVD) PIPELINE HIGHLIGHTS Peripheral Vascular Disease (PVD) is one of the widely researched conditions during 2020 with 34 companies actively focusing on realizing pip...

July 2020 164 pages

Peritonitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Peritonitis PIPELINE HIGHLIGHTS Peritonitis is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Peritonitis...

July 2020 48 pages

Postoperative Ileus pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Postoperative Ileus PIPELINE HIGHLIGHTS Postoperative Ileus is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Developmen...

July 2020 52 pages

Pressure Ulcers pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Pressure Ulcers PIPELINE HIGHLIGHTS Pressure Ulcers is one of the widely researched conditions during 2020 with 6 companies actively focusing on realizing pipeline’s potential. Development of Pre...

July 2020 45 pages

Primary Biliary Cholangitis (Cirrhosis) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Primary Biliary Cholangitis (Cirrhosis) PIPELINE HIGHLIGHTS Primary Biliary Cholangitis (Cirrhosis) is one of the widely researched conditions during 2020 with 20 companies actively focusing on r...

July 2020 102 pages

Primary Hyperoxaluria pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Primary Hyperoxaluria PIPELINE HIGHLIGHTS Primary Hyperoxaluria is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential. Develo...

July 2020 49 pages

Primary Sclerosing Cholangitis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Primary Sclerosing Cholangitis PIPELINE HIGHLIGHTS Primary Sclerosing Cholangitis is one of the widely researched conditions during 2020 with 19 companies actively focusing on realizing pipeline’...

July 2020 114 pages

Pruritus pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Pruritus PIPELINE HIGHLIGHTS Pruritus is one of the widely researched conditions during 2020 with 38 companies actively focusing on realizing pipeline’s potential. Development of Pruritus medicin...

July 2020 189 pages

Pulmonary Arterial Hypertension pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Pulmonary Arterial Hypertension PIPELINE HIGHLIGHTS Pulmonary Arterial Hypertension is one of the widely researched conditions during 2020 with 72 companies actively focusing on realizing pipelin...

July 2020 290 pages

Pulmonary Embolism pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Pulmonary Embolism PIPELINE HIGHLIGHTS Pulmonary Embolism is one of the widely researched conditions during 2020 with 8 companies actively focusing on realizing pipeline’s potential. Development...

July 2020 52 pages

Raynauds Disease pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Raynauds Disease PIPELINE HIGHLIGHTS Raynauds Disease is one of the widely researched conditions during 2020 with 4 companies actively focusing on realizing pipeline’s potential. Development of R...

July 2020 35 pages

Reflux Esophagitis (Gastroesophageal Reflux) pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Reflux Esophagitis (Gastroesophageal Reflux) PIPELINE HIGHLIGHTS Reflux Esophagitis (Gastroesophageal Reflux) is one of the widely researched conditions during 2020 with 18 companies actively foc...

July 2020 98 pages

Restenosis pipeline Research Monitor, 2020- Drugs, Companies, Clinical Trials, R&D pipeline updates, status and outlook

US$ 1,439.00

2020 Restenosis PIPELINE HIGHLIGHTS Restenosis is one of the widely researched conditions during 2020 with 2 companies actively focusing on realizing pipeline’s potential. Development of Restenosis me...

July 2020 32 pages

Filters

Search

Categories

60
12,968
1,223
4,429
2
1
10,890
2,818
15,138
67
8,921
1
1,229
586

Publishers

58,333

Regions

1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
58,296

Price

Date

Pages

Offers